PharmaSeq

Home Technology Patents

Patents

Since its founding in 1999, PharmaSeq has developed a significant amount of new technology and has eleven issued patents, three US, four world patents published and six patents currently pending. These include patents covering tagging and tracking applications as well as approaches in the field of molecular and immunoassay diagnostics — specifically in the areas of binding biological molecules to the p-Chip®, high throughput and automated reading devices and proprietary assay content. The p-Chip itself is the subject of an issued US patent.